Knee Osteoarthritis 

Study Option 1:

The primary objective of this study is to evaluate the safety and efficacy of two doses of CNTX-6970 for the treatment of pain related to OA of the knee compared to placebo. CNTX-6970 is being developed as a new treatment for chronic pain, including painful osteoarthritis of the knee.

Study Option 2:

The SKOAP Study is a Sequenced strategy for improving outcomes in people with Knee OsteoArthritis Pain (SKOAP). It is a national study, funded by the Helping to End Addiction Long-term® Initiative, or NIH HEAL Initiative®.

SKOAP compares non-opioid pain treatments with the goal of reducing KOA pain and improving function to find out what treatments work best for which patients.